Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells in non-small-cell lung cancer5 and gastric cancer invasiveness by NF-κB-mediated matrix metalloproteinases 2 and 9 expression6. This evidence concerns the gene NFKB1 and cancer.